Finance

Lists
4151:TYO
Kyowa Kirin Co Ltd
၂,၂၆၆.၀၀ JP¥
+၀.၈၉%
(+၂၀.၀၀) 1D
စက် ၂၉, GMT+၉ ၁၅:၃၀:၀၀  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4151...
Open
၂,၂၃၆ JP¥
High
၂,၂၆၆ JP¥
Low
၂,၂၃၄ JP¥
Mkt. cap
ဋေ ၁.၁၉ သိန်း
Avg. vol.
၁.၆၅ သန်း
Volume
၁.၇၂ သန်း
Dividend
၂.၉၆%
Quarterly dividend
၁၇ JP¥
Ex-dividend date
၂၀၂၆ ဇွန် ၂၉
P/E ratio
၁၄.၅၈
52-wk high
၂,၉၁၂ JP¥
52-wk low
၂,၁၀၉ JP¥
EPS
၁၅၅ JP¥
Shares outstanding
၅၄.၇၄ ကုဋေ
No. of employees
၅ ထောင်
Open
၂,၂၃၆ JP¥
High
၂,၂၆၆ JP¥
Low
၂,၂၃၄ JP¥
Mkt. cap
ဋေ ၁.၁၉ သိန်း
Avg. vol.
၁.၆၅ သန်း
Volume
၁.၇၂ သန်း
Dividend
၂.၉၆%
Quarterly dividend
၁၇ JP¥
Ex-dividend date
၂၀၂၆ ဇွန် ၂၉
P/E ratio
၁၄.၅၈
52-wk high
၂,၉၁၂ JP¥
52-wk low
၂,၁၀၉ JP¥
EPS
၁၅၅ JP¥
Shares outstanding
၅၄.၇၄ ကုဋေ
No. of employees
၅ ထောင်
News stories
From web sources and news partners
TipRanks
TipRanks
·
ပြီးခဲ့သည့် ၂ နာရီ
Kyowa Kirin’s KK4277 Lupus Trial Completion: What Investors Should Watch Next
Yahoo! Finance Canada
Yahoo! Finance Canada
·
ပြီးခဲ့သည့် ၆ နာရီ
Stocks in play: Knight Therapeutics Inc.
Profile
Kyowa Kirin Co., Ltd. is a Japanese pharmaceutical and biotechnology company under the Kirin Holdings, and was among the 40 largest in the world by revenue in 2012. The company is headquartered in Chiyoda-ku, Tokyo and is a member of the Nikkei 225 stock index. Wikipedia
About Kyowa Kirin Co Ltd
CEOMasashi Miyamoto
Employees၅.၁၆ ထောင်
Founded၁၉၄၉ ဇူ ၁
Headquarters-
Sector-
Last report
၂၀၂၆ ဩ ၃
Fiscal period
Q2 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
ဋေ ၁.၄၅ သ / ဋေ ၁.၃၃ သ
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၁.၁၉ သ
ဋေ ၁.၄၇ သ
ဋေ ၁.၁၈ သ
ဋေ ၁.၄၅ သ
Cost of goods sold
ဋေ ၂.၈၂ ထ
ဋေ ၃.၇၉ ထ
ဋေ ၃.၀၂ ထ
ဋေ ၃.၆၁ ထ
Cost of revenue
ဋေ ၂.၈၂ ထ
ဋေ ၃.၇၉ ထ
ဋေ ၃.၀၂ ထ
ဋေ ၃.၆၁ ထ
Research and development expenses
ဋေ ၂.၄၃ ထ
ဋေ ၂.၄၃ ထ
ဋေ ၂.၇၂ ထ
ဋေ ၁.၉၂ ထ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
ဋေ ၃.၈၇ ထ
ဋေ ၃.၁၃ ထ
ဋေ ၄.၁၁ ထ
ဋေ ၄.၃၇ ထ
Operating expense
ဋေ ၆.၃၁ ထ
ဋေ ၇.၂၂ ထ
ဋေ ၇.၁၀ ထ
ဋေ ၉.၄၅ ထ
Total operating expenses
ဋေ ၉.၁၃ ထ
ဋေ ၁.၁၀ သ
ဋေ ၁.၀၁ သ
ဋေ ၁.၃၁ သ
Operating income
ဋေ ၂.၇၅ ထ
ဋေ ၃.၇၄ ထ
ဋေ ၁.၇၂ ထ
ဋေ ၁.၄၅ ထ
Other non operating income
-၁၆၈.၈၀ ဋေ
ဋေ ၁.၃၅ ထ
-၇၇၁.၄၀ ဋေ
၇၇၁.၄၀ ဋေ
EBT including unusual items
ဋေ ၂.၅၉ ထ
ဋေ ၃.၉၃ ထ
ဋေ ၁.၃၉ ထ
ဋေ ၂.၃၅ ထ
EBT excluding unusual items
ဋေ ၂.၅၉ ထ
ဋေ ၅.၁၂ ထ
ဋေ ၁.၃၉ ထ
ဋေ ၂.၃၅ ထ
Income tax expense
၉၆၆.၉၀ ဋေ
၄၈၅.၆၀ ဋေ
၁၈၉.၂၀ ဋေ
၄၉၅.၅၀ ဋေ
Effective tax rate
၃၇.၂၆%
၁၂.၃၆%
၁၃.၅၉%
၂၁.၀၅%
Other operating expenses
-
၃၉၁.၇၀ ဋေ
-
ဋေ ၂.၈၆ ထ
Net income
ဋေ ၁.၆၃ ထ
ဋေ ၃.၄၄ ထ
ဋေ ၁.၂၀ ထ
ဋေ ၁.၈၆ ထ
Net profit margin
၁၃.၇၀%
၂၃.၃၇%
၁၀.၁၆%
၁၂.၈၀%
Earnings per share
-
-
-
-
Interest and investment income
၁၁၈.၂၀ ဋေ
၂၇၀.၉၀ ဋေ
၅၆၇.၇၀ ဋေ
၁၅၈.၂၀ ဋေ
Interest expense
-၅၂.၉၀ ကုဋေ
-၂.၈၀ ကုဋေ
-၂၂၇.၀၀ ဋေ
-
Net interest expenses
၆၅.၃၀ ကုဋေ
၂၆၈.၁၀ ဋေ
၃၄၀.၇၀ ဋေ
၁၅၈.၂၀ ဋေ
Depreciation and amortization charges
-
ဋေ ၁.၂၅ ထ
-
-၂၇၈.၁၀ ဋေ
EBITDA
ဋေ ၃.၄၀ ထ
ဋေ ၄.၄၇ ထ
ဋေ ၂.၄၉ ထ
ဋေ ၂.၂၃ ထ
Gain or loss from assets sale
-
၂၇၇.၂၀ ဋေ
-
၅၅၅.၆၀ ဋေ
AI content may include mistakes. Learn more
Google အက်ပ်များ